KLRC1 and neoplasm: In an in vivo study on cancer vaccination using mouse tumor models, the impact of therapeutic vaccines was greatly potentiated by disruption of the NKG2A/Qa-1b (conserved ortholog of HLA-E) axis even in a PD-1-refractory mouse model.